Previous evidence shows that G. lucidum can improve intestinal flora dysbiosis and reduce AOM/DSS-induced colitis and tumorigenesis by inhibiting TLR4/MyD88/NF-κB pathway (Guo et al., 2021). This evidence concerns the gene MYD88 and colitis.